Weight Loss at the Spa at West Glen

Semaglutide and Tirzepatide in Des Moines, IA

FAQS

What is Semaglutide and Tirzepatide:

Semaglutide is a revolutionary GLP-1 receptor agonist that was originally developed for patients with Type 2 diabetes, but when providers and pharmaceutical developers noticed how much weight their patients were losing, they began to study Semaglutide exclusively for weight loss. A series of clinical trials known as the STEP clinical trials deomstrated that almost 90% of patients lost 5% or more of their body weight. In June of 2022, the FDA approved Semaglutide for weight loss.

How does Semaglutide/ Tirzepatide work?

These medications work to:

-increase insulin production
-decrease glucagon synthesis
-delay gastric emptying
-suppress hunger. It signals your brain that you are full so you can lose weight without feeling like you are depriving yourself.

What are potential side effects?

-Commonly reported GI side effects- nausea, vomiting, diarrhea, constipation, abdominal pain.
-Site reactions
-Fatigue
-Headaches
-Alcohol intolerance

  • Under 18 years old

  • Pregnant/breastfeeding

  • Type 1 diabetes mellitus

  • Diabetes ketoacidosis

  • Hypersensitivity to Semaglutide/Tirzepatide or any components of these medications

  • Personal or family history of medullary thyroid carcinoma

  • History of multiple endocrine neoplasia syndrome

  • History of pancreatitis

  • End stage renal disease (on dialysis)

  • BMI <25

  • Patients with diabetic retinopathy

Who is NOT a candidate for Weight loss at The Spa at West Glen?

Who IS a candidate?

-Everyone else*

**Health history, medications and body weight information will be carefully reviewed by a licensed provider to determine each candidate’s eligibility.